These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7536698)

  • 1. [Hysteroscopy in the diagnosis and treatment of residua after evacuation of hydatidiform mole].
    Wilczak M; Sajdak S; Woźniak J; Cwojdziński M; Nowak-Markwitz E; Pisarski T
    Ginekol Pol; 1994 Sep; 65(9):522-6. PubMed ID: 7536698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydatidiform mole and post-evacuation regression patterns of serum beta human chorionic gonadotrophin.
    Kamariah K; Satgunasingam N; Nasri NM; Ng KY
    Med J Malaysia; 1993 Mar; 48(1):40-5. PubMed ID: 7688063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum SP1 and hCG beta-subunit (hCG beta) levels in choriocarcinoma, invasive mole, and hydatidiform mole--clinical significance of SP1/hCG beta ratio.
    Sakuragi N
    Gynecol Oncol; 1982 Jun; 13(3):393-8. PubMed ID: 6178652
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibin as a marker for hydatidiform mole: a comparative study with the determinations of intact human chorionic gonadotrophin and its free beta-subunit.
    Badonnel Y; Barbé F; Legagneur H; Poncelet E; Schweitzer M
    Clin Endocrinol (Oxf); 1994 Aug; 41(2):155-62. PubMed ID: 7523000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Case observations on the significance of early pregnancy factor as a tumor marker].
    Bojahr B; Straube W; Reddemann H
    Zentralbl Gynakol; 1993; 115(3):125-8. PubMed ID: 7682025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
    Zhang WY; Yen GL
    Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The level of beta-subunit of human chorionic gonadotrophin in benign hydatidiform mole.
    Tangtakul S; Srisupundit S
    J Med Assoc Thai; 1988 Mar; 71 Suppl 1():111-3. PubMed ID: 2458424
    [No Abstract]   [Full Text] [Related]  

  • 8. Hydatidiform moles.
    Heath JM; Bu TH; Brereton WF
    Am Fam Physician; 1985 May; 31(5):123-31. PubMed ID: 2581433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Uterine tumor, HCG excess and hyperthyroidism in a 51-year old woman].
    Mödl BM; Nentwich K; Hitzler HJ; Lorch R; Keller E; Pfafferott C
    Internist (Berl); 2001 Mar; 42(3):411-5. PubMed ID: 11277025
    [No Abstract]   [Full Text] [Related]  

  • 10. Natural history of hydatidiform mole after primary evacuation.
    Lurain JR; Brewer JI; Torok EE; Halpern B
    Am J Obstet Gynecol; 1983 Mar; 145(5):591-5. PubMed ID: 6829636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
    Elmer DB; Granai CO; Ball HG; Curry SL
    Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands.
    Franke HR; Risse EK; Kenemans P; Houx PC; Stolk JG; Vooijs GP
    Obstet Gynecol; 1983 Oct; 62(4):467-73. PubMed ID: 6888825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of hysteroscopy in diagnosis and management of trophoblastic disease].
    Suzuki A; Kawaguchi K; Konishi I; Ida K; Fujii S; Matsuura S
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Feb; 36(2):255-60. PubMed ID: 6321615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of oral contraceptives on the postmolar human chorionic gonadotropin regression curve.
    Morrow P; Nakamura R; Schlaerth J; Gaddis O; Eddy G
    Am J Obstet Gynecol; 1985 Apr; 151(7):906-14. PubMed ID: 2580438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation.
    Braga A; Maestá I; Matos M; Elias KM; Rizzo J; Viggiano MG
    Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
    Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
    Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Hook effect" in complete hydatidiform molar pregnancy: a falsely low level of beta-HCG.
    Levavi H; Neri A; Bar J; Regev D; Nordenberg J; Ovadia J
    Obstet Gynecol; 1993 Oct; 82(4 Pt 2 Suppl):720-1. PubMed ID: 7690921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum relaxin in patients with hydatidiform mole.
    Seki K; Uesato T; Tabei T; Kato K
    Obstet Gynecol; 1986 Mar; 67(3):381-3. PubMed ID: 3945450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can circulating M30 and M65 levels be beneficial markers in the diagnosis and management of patients with complete hydatidiform mole?
    Incebiyik A; Vural M; Camuzcuoglu H; Taskin A; Camuzcuoglu A; Hilali NG; Aksoy N
    Wien Klin Wochenschr; 2016 Dec; 128(Suppl 8):566-571. PubMed ID: 25869758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molar pregnancy in a 60-year-old woman.
    Davidson SA; Gottesfeld J; La Rosa FG
    Int J Gynaecol Obstet; 1997 Jan; 56(1):53-5. PubMed ID: 9049695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.